These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15492837)

  • 1. p16INK4a polymorphism: associations with tumour progression in patients with sporadic colorectal cancer.
    McCloud JM; Sivakumar R; Greenhough A; Elder J; Jones PW; Deakin M; Elder JB; Fryer AA; Hoban PR
    Int J Oncol; 2004 Nov; 25(5):1447-52. PubMed ID: 15492837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in the glutathione S-transferase mu cluster are associated with tumour progression and patient outcome in colorectal cancer.
    Holley SL; Rajagopal R; Hoban PR; Deakin M; Fawole AS; Elder JB; Elder J; Smith V; Strange RC; Fryer AA
    Int J Oncol; 2006 Jan; 28(1):231-6. PubMed ID: 16328000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin promoter polymorphisms and prognosis in colorectal cancer.
    Wilkening S; Tavelin B; Canzian F; Enquist K; Palmqvist R; Altieri A; Hallmans G; Hemminki K; Lenner P; Försti A
    Carcinogenesis; 2008 Jun; 29(6):1202-6. PubMed ID: 18448485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of polymorphisms within 5' and 3' untranslated regions of thymidylate synthase gene modulates survival in 5 fluorouracil-treated colorectal cancer patients.
    Fernández-Contreras ME; Sánchez-Hernández JJ; González E; Herráez B; Domínguez I; Lozano M; García De Paredes ML; Muñoz A; Gamallo C
    Int J Oncol; 2009 Jan; 34(1):219-29. PubMed ID: 19082493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutathione S-transferase T1 polymorphisms are associated with outcome in colorectal cancer.
    Rajagopal R; Deakin M; Fawole AS; Elder JB; Elder J; Smith V; Strange RC; Fryer AA
    Carcinogenesis; 2005 Dec; 26(12):2157-63. PubMed ID: 16051638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E-selectin gene S128R polymorphism is associated with poor prognosis in patients with stage II or III colorectal cancer.
    Hebbar M; Adenis A; Révillion F; Duhamel A; Romano O; Truant S; Libersa C; Giraud C; Triboulet JP; Pruvot FR; Peyrat JP
    Eur J Cancer; 2009 Jul; 45(10):1871-6. PubMed ID: 19361981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A functional polymorphism (-347 G-->GA) in the E-cadherin gene is associated with colorectal cancer.
    Shin Y; Kim IJ; Kang HC; Park JH; Park HW; Jang SG; Lee MR; Jeong SY; Chang HJ; Ku JL; Park JG
    Carcinogenesis; 2004 Nov; 25(11):2173-6. PubMed ID: 15231691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of single nucleotide polymorphism in the promoter and protein expression of the chemokine eotaxin-1 in colorectal cancer patients.
    Wågsäter D; Löfgren S; Hugander A; Dienus O; Dimberg J
    World J Surg Oncol; 2007 Jul; 5():84. PubMed ID: 17672898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in the transforming growth factor beta 1 pathway in relation to colorectal cancer progression.
    Försti A; Li X; Wagner K; Tavelin B; Enquist K; Palmqvist R; Altieri A; Hallmans G; Hemminki K; Lenner P
    Genes Chromosomes Cancer; 2010 Mar; 49(3):270-81. PubMed ID: 19998449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E gene polymorphism and colorectal cancer: gender-specific modulation of risk and prognosis.
    Watson MA; Gay L; Stebbings WS; Speakman CT; Bingham SA; Loktionov A
    Clin Sci (Lond); 2003 May; 104(5):537-45. PubMed ID: 12529167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of tumour-infiltrating lymphocytes and apoptosis in colitis-associated neoplasia: comparison with sporadic colorectal cancer.
    Michael-Robinson JM; Pandeya N; Walsh MD; Biemer-Huttmann AE; Eri RD; Buttenshaw RL; Lincoln D; Clouston AD; Jass JR; Radford-Smith GL
    J Pathol; 2006 Feb; 208(3):381-7. PubMed ID: 16315333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphism and circulating levels of the chemokine CXCL12 in colorectal cancer patients.
    Dimberg J; Hugander A; Löfgren S; Wågsäter D
    Int J Mol Med; 2007 Jan; 19(1):11-5. PubMed ID: 17143542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-penetrance alleles predisposing to sporadic colorectal cancers: a French case-controlled genetic association study.
    Küry S; Buecher B; Robiou-du-Pont S; Scoul C; Colman H; Le Neel T; Le Houérou C; Faroux R; Ollivry J; Lafraise B; Chupin LD; Sébille V; Bézieau S
    BMC Cancer; 2008 Nov; 8():326. PubMed ID: 18992148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotype and haplotype analysis of cell cycle genes in sporadic colorectal cancer in the Czech Republic.
    Polakova V; Pardini B; Naccarati A; Landi S; Slyskova J; Novotny J; Vodickova L; Bermejo JL; Hanova M; Smerhovsky Z; Tulupova E; Kumar R; Hemminki K; Vodicka P
    Hum Mutat; 2009 Apr; 30(4):661-8. PubMed ID: 19224585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SDF-1alpha G801A polymorphism predicts lymph node metastasis in stage T3 colorectal cancer.
    Chang SC; Lin PC; Yang SH; Wang HS; Li AF; Lin JK
    Ann Surg Oncol; 2009 Aug; 16(8):2323-30. PubMed ID: 19472013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A C/T polymorphism in the urokinase-type plasminogen activator gene in colorectal cancer.
    Przybylowska K; Smolarczyk K; Blasiak J; Kulig A; Romanowicz-Makowska H; Dziki A; Ulanska J; Pander B
    J Exp Clin Cancer Res; 2001 Dec; 20(4):569-72. PubMed ID: 11876553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1 receptor antagonist gene polymorphism in human colorectal cancer.
    Viet HT; Wågsäter D; Hugander A; Dimberg J
    Oncol Rep; 2005 Oct; 14(4):915-8. PubMed ID: 16142351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of interleukin-8 and interleukin-10 on sporadic colon cancer development and progression.
    Cacev T; Radosević S; Krizanac S; Kapitanović S
    Carcinogenesis; 2008 Aug; 29(8):1572-80. PubMed ID: 18628251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No association between genetic polymorphisms in NAD(P)H oxidase p22phox and paraoxonase 1 and colorectal cancer risk.
    Van Der Logt EM; Janssen CH; Van Hooijdonk Z; Roelofs HM; Wobbes T; Nagengast FM; Peters WH
    Anticancer Res; 2005; 25(2B):1465-70. PubMed ID: 15865106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterozygosity for interleukin-18 -607 A/C polymorphism is associated with risk for colorectal cancer.
    Nikiteas N; Yannopoulos A; Chatzitheofylaktou A; Tsigris C
    Anticancer Res; 2007; 27(6B):3849-53. PubMed ID: 18225542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.